203 related articles for article (PubMed ID: 23248646)
1. miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome.
Brzustowicz LM; Bassett AS
Front Genet; 2012; 3():291. PubMed ID: 23248646
[TBL] [Abstract][Full Text] [Related]
2. Deletion Extents Are Not the Cause of Clinical Variability in 22q11.2 Deletion Syndrome: Does the Interaction between DGCR8 and miRNA-CNVs Play a Major Role?
Bertini V; Azzarà A; Legitimo A; Milone R; Battini R; Consolini R; Valetto A
Front Genet; 2017; 8():47. PubMed ID: 28507561
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome.
Ying S; Heung T; Zhang Z; Yuen RKC; Bassett AS
Front Genet; 2022; 13():812183. PubMed ID: 35495153
[TBL] [Abstract][Full Text] [Related]
4. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.
Cleynen I; Engchuan W; Hestand MS; Heung T; Holleman AM; Johnston HR; Monfeuga T; McDonald-McGinn DM; Gur RE; Morrow BE; Swillen A; Vorstman JAS; Bearden CE; Chow EWC; van den Bree M; Emanuel BS; Vermeesch JR; Warren ST; Owen MJ; Chopra P; Cutler DJ; Duncan R; Kotlar AV; Mulle JG; Voss AJ; Zwick ME; Diacou A; Golden A; Guo T; Lin JR; Wang T; Zhang Z; Zhao Y; Marshall C; Merico D; Jin A; Lilley B; Salmons HI; Tran O; Holmans P; Pardinas A; Walters JTR; Demaerel W; Boot E; Butcher NJ; Costain GA; Lowther C; Evers R; van Amelsvoort TAMJ; van Duin E; Vingerhoets C; Breckpot J; Devriendt K; Vergaelen E; Vogels A; Crowley TB; McGinn DE; Moss EM; Sharkus RJ; Unolt M; Zackai EH; Calkins ME; Gallagher RS; Gur RC; Tang SX; Fritsch R; Ornstein C; Repetto GM; Breetvelt E; Duijff SN; Fiksinski A; Moss H; Niarchou M; Murphy KC; Prasad SE; Daly EM; Gudbrandsen M; Murphy CM; Murphy DG; Buzzanca A; Fabio FD; Digilio MC; Pontillo M; Marino B; Vicari S; Coleman K; Cubells JF; Ousley OY; Carmel M; Gothelf D; Mekori-Domachevsky E; Michaelovsky E; Weinberger R; Weizman A; Kushan L; Jalbrzikowski M; Armando M; Eliez S; Sandini C; Schneider M; Béna FS; Antshel KM; Fremont W; Kates WR; Belzeaux R; Busa T; Philip N; Campbell LE; McCabe KL; Hooper SR; Schoch K; Shashi V; Simon TJ; Tassone F; Arango C; Fraguas D; García-Miñaúr S; Morey-Canyelles J; Rosell J; Suñer DH; Raventos-Simic J; ; Epstein MP; Williams NM; Bassett AS
Mol Psychiatry; 2021 Aug; 26(8):4496-4510. PubMed ID: 32015465
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
6. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.
Saito R; Koebis M; Nagai T; Shimizu K; Liao J; Wulaer B; Sugaya Y; Nagahama K; Uesaka N; Kushima I; Mori D; Maruyama K; Nakao K; Kurihara H; Yamada K; Kano M; Fukada Y; Ozaki N; Aiba A
Transl Psychiatry; 2020 Feb; 10(1):35. PubMed ID: 32066675
[TBL] [Abstract][Full Text] [Related]
8. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
9. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms.
Guna A; Butcher NJ; Bassett AS
J Neurodev Disord; 2015; 7(1):18. PubMed ID: 26137170
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome.
Merico D; Costain G; Butcher NJ; Warnica W; Ogura L; Alfred SE; Brzustowicz LM; Bassett AS
Front Neurol; 2014; 5():238. PubMed ID: 25484875
[TBL] [Abstract][Full Text] [Related]
11. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
[TBL] [Abstract][Full Text] [Related]
12. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.
Forstner AJ; Degenhardt F; Schratt G; Nöthen MM
Front Mol Neurosci; 2013 Dec; 6():47. PubMed ID: 24367288
[TBL] [Abstract][Full Text] [Related]
14. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
[TBL] [Abstract][Full Text] [Related]
15. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
Van L; Boot E; Bassett AS
Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
[TBL] [Abstract][Full Text] [Related]
16. Review: Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to Schizophrenia.
Kolar D; Krajcovic B; Kleteckova L; Kuncicka D; Vales K; Brozka H
Schizophr Bull; 2023 Nov; 49(6):1637-1653. PubMed ID: 37379469
[TBL] [Abstract][Full Text] [Related]
17. The Potential Role of Dysregulated miRNAs in Adolescent Idiopathic Scoliosis and 22q11.2 Deletion Syndrome.
Montemurro N; Ricciardi L; Scerrati A; Ippolito G; Lofrese G; Trungu S; Stoccoro A
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422101
[No Abstract] [Full Text] [Related]
18. Partial microduplication in the histone acetyltransferase complex member KANSL1 is associated with congenital heart defects in 22q11.2 microdeletion syndrome patients.
León LE; Benavides F; Espinoza K; Vial C; Alvarez P; Palomares M; Lay-Son G; Miranda M; Repetto GM
Sci Rep; 2017 May; 7(1):1795. PubMed ID: 28496102
[TBL] [Abstract][Full Text] [Related]
19. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
[TBL] [Abstract][Full Text] [Related]
20. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.
Scott JA; Goodrich-Hunsaker N; Kalish K; Lee A; Hunsaker MR; Schumann CM; Carmichael OT; Simon TJ
J Psychiatry Neurosci; 2016 Apr; 41(3):203-13. PubMed ID: 26599134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
